Table 2.
Patient stable on warfarin with high time in therapeutic range and patient decision to forgo the reduced risk of intracranial hemorrhage |
Mechanical prosthetic valves |
Clinically significant mitral stenosis |
Severe renal insufficiency |
Inability to afford novel agents |